An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients (Q64351760)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients |
clinical trial |
Statements
A Phase III, Open-label, Extension Trial of ECU-NMO-301 to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO) (English)
0 references
January 2015
0 references
June 2020
0 references
119
0 references
18 year
0 references